Acitretin, a systemic retinoid for the treatment of psoriasis - Current state of knowledge;Acytretyna, systemowy retinoid stosowany w leczeniu łuszczycy - Aktualny stan wiedzy

Postepy Dermatologii i Alergologii

Volumn 28, Issue 4, 2011, Pages 285-301

  Pastuszka, Marta ^a   Kaszuba, Andrzej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Acitretin; Efficacy; Psoriasis; Safety

Indexed keywords

AMINOTRANSFERASE; CALCIPOTRIOL; CYCLOSPORIN; ETANERCEPT; ETRETIN; ETRETINATE; HIGH DENSITY LIPOPROTEIN; HYDROXYCHLOROQUINE; LOW DENSITY LIPOPROTEIN; METHOTREXATE; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; TRIACYLGLYCEROL;

AMINOTRANSFERASE BLOOD LEVEL; ARTHRALGIA; BLEPHARITIS; BONE DISEASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEILITIS; CLINICAL EFFECTIVENESS; CONJUNCTIVITIS; DARIER DISEASE; DISCOID LUPUS ERYTHEMATOSUS; DOSE RESPONSE; DROWSINESS; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ELIMINATION; DRUG ERUPTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; DRY SKIN; EMBRYOPATHY; ERYTHEMA; ERYTHRODERMA; FATIGUE; HAIR LOSS; HUMAN; HYDROCEPHALUS; ICHTHYOSIS; INTRACRANIAL HYPERTENSION; KERATODERMA; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; LIPOPROTEIN BLOOD LEVEL; LOW DRUG DOSE; MALAISE; MELANOMA; MICROCEPHALY; MICROPHTHALMIA; MONOTHERAPY; MUCOSAL BLEEDING; MULTICENTER STUDY (TOPIC); MYALGIA; MYCOSIS FUNGOIDES; NAUSEA; PARONYCHIA; PITYRIASIS RUBRA PILARIS; PSORIASIS; PSORIASIS SEVERITY INDEX; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS; PUSTULOSIS PALMOPLANTARIS; PUVA; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINOID DERMATITIS; REVIEW; RHINITIS; SIDE EFFECT; SWEATING; TERATOGENICITY; TOXIC HEPATITIS; TREATMENT CONTRAINDICATION; TREATMENT DURATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; ULTRAVIOLET IRRADIATION; UNSPECIFIED SIDE EFFECT; VERRUCA VULGARIS; VULVOVAGINITIS;

EID: 80052435886     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Ormerod A.D., Campalani E., Goodfield M.J.D. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol 2010; 162: 952-963
2. Sbidian E., Maza A., Montaudie H., et al. Efficacy and safety of oral retinoids in different psoriasis subtypes: A systemic literature review. J Eur Acad Dermatol Venereol 2011; 25: 28-33.
3. Zheng Z.S., Polakowska R., Johnson A., et al. Transcriptional control of epidermal growth factor receptor by retinoic acid. Cell Growth Differ 1992; 3: 225-232
4. Imcke E., Ruszczak Z., Mayer-da Silva A., et al. Cultivation of human dermal microvascular endothelial cells in vitro: Immunocytochemical and ultrastructural characterization and effect of treatment with three synthetic retinoids. Arch Dermatol Res 1991; 283: 149-157
5. Becherel P.A., Mossalayi M.D., LeGoff L., et al. Mechanism of anti-inflammatory action of retinoids on keratinocytes. Lancet 1994; 344: 1570-1571 (Pubitemid 24357722)
6. McNamara P.J., Jewell R.C., Jensen B.K., et al. Food increases the bioavailability of acitretin. J Clin Pharmacol 1988; 28: 1051-1055 (Pubitemid 19013419)
7. Wiegand U.W., Chou R.C. Pharmacokinetics of acitretin and etretinate. J Am Acad Dermatol 1998; 39: 25-33.
8. Lucek R.W., Colburn W.A. Clinical pharmacokinetics of the retinoids. Clin Pharmacokinet 1985; 10: 38-62. (Pubitemid 15198240)
9. Allen J.G., Bloxham D.P. The pharmacology and pharmacokinatics of the retinoids. Pharmacol Ther 1989; 40: 1-27.
10. Larsen F.G., Jakobsen P., Knudsen J., et al. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol. J Invest Dermatol 1993; 100: 623-627 (Pubitemid 23128356)
11. Schmitt-Hoffmann A.H., Dittrich S., Saulnier E., Schenk P. Mechanistic studies on the ethyl-estrification of acitretin by human liver preparations in vitro. Life Sci 1995; 57: 407-412
12. Larsen F.G., Steinkjer B., Jakobsen P., et al. Acitretin is converted to etretinate only during concomitant alcohol intake. Br J Dermatol 2000; 143: 1164-1169 (Pubitemid 32052750)
13. Laugier J.P., De Sousa G., Bun H., et al. Acitretin biotransformation into etretinate: Role of ethanol on in-vitro hepatic metabolism. Dermatology 1994; 188: 122-125 (Pubitemid 24031332)
14. Gupta A.K., Goldfarb M.T., Ellis C.N., et al. Side-effect profile of acitretin therapy in psoriasis. J Am Acad Dermatol 1989; 20: 1088-1093 (Pubitemid 19151521)
15. Magis N.L., Blummel J.J., Van De Kerkhof P.C., et al. The treatment of psoriasis with etretinate and acitretin: A follow up of actual use. Eur J Dermatol 2000; 10: 517-521
16. Olsen E.A., Weed W.W., Meyer C.J., et al. A double-blind, placebo-controlled trial of acitretin for the treatment of psoriasis. J Am Acad Dermatol 1989; 21: 681-686 (Pubitemid 19251725)
17. Murray H.E., Anhalt A.W., Lessard R., et al. A 12- Month treatment of severe psoriasis with acitretin- Results of a Canadian open multicenter study. J Am Acad Dermatol 1991; 24: 598-602.
18. Kragballe K., Jansen C.T., Geiger J.M., et al. A double- Blind comparison of acitretin and etretinate in the treatment of severe psoriasis- Results of a Nordic multicenter study. Acta Derm Venereol 1989; 69: 35-40. (Pubitemid 19028329)
19. Lassus A., Geiger J.M., Nyblom M., et al. Treatment of severe psoriasis with etretin (RO-1670). Br J Dermatol 1987; 117: 333-341 (Pubitemid 17126010)
20. Goldfarb M.T., Ellis C.N., Gupta A.K., et al. Acitretin improves psoriasis in a dose-dependent fashion. J Am Acad Dermatol 1988; 18: 655-662
21. Gollnick H., Bauer R., Brindley C., et al. Acitretin versus etretinate in psoriasis - Clinical and pharmacokinetic results of a German multicenter study. J Am Acad Dermatol 1988; 19: 458-468
22. Lauharanta J., Geiger J.M. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis. Br J Dermatol 1989; 121: 107-112 (Pubitemid 19177127)
23. Lowe N.J., Prystowsky J.H., Bourget T., et al. Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol 1991; 24: 591-594
24. Lebwohl M., Menter A., Koo J., et al. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol 2004; 50: 416-430 (Pubitemid 38316135)
25. Van De Kerkhof P.C., Cambazard F., Hutchinson P.E., et al. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis. Br J Dermatol 1998; 138: 84-89 (Pubitemid 28077942)
26. Gisondi P., Del Giglio M., Cotena C., et al. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: A 24-week, randomized, controlled, investigator-blinded pilot trial. Br J Dermatol 2008; 158: 1345-1349 (Pubitemid 351692891)
27. Grozdev I.S., Van Voorhees A.S., Gottlieb A.B., et al. Psoriasis in the elderly: From the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2010; 62: 654-656
28. Harrison P.V., Peat M., James R., Orrell D. Methotrexate and retinoids in combination for psoriasis. Lancet 1987; ii: 512. (Pubitemid 17126758)
29. Kuijpers A.L.A., Van Dooren-Geebe R.J., Van De Kerkhof P.C.M. Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis. Dermatology 1997; 194: 88-90. (Pubitemid 27047346)
30. Schroder K., Zaun H., Holzmann H., et al. Pustulosis palmoplantaris. Clinical and histological changes during etretin (acitretin) therapy. Acta Derm Venereol 1989; 146: 111-116 (Pubitemid 20013759)
31. Lassus A., Geiger J.M. Acitretin and etretinate in the treatment of palmoplantar pustulosis: A double-blind comparative trial. Br J Dermatol 1988; 119: 755-759 (Pubitemid 19002627)
32. Roenigk H.H. Acitretin combination therapy. J Am Acad Dermatol 1999; 41: S18-S21 (Pubitemid 29416463)
33. Chen K., Craig J.C., Shumack S. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: A systematic review of randomized controlled trials. Br J Dermatol 2005; 152: 518-523 (Pubitemid 40547126)
34. Blanchet-Bardon C., Nazzaro V., Rognin C., et al. Acitretin in the treatment of severe disorders of keratinization. Results of an open study. J Am Acad Dermatol 1991; 24: 982-986
35. Kullavanijaya P., Kulthanan K. Clinical efficacy and side effects of acitretin on the disorders of keratinization: A one-year study. J Dermatol 1993; 20: 501-506 (Pubitemid 23274612)
36. Al-Mutairi N., Joshi A., Nour-Eldin O. Punctate palmoplantar keratoderma (Buschke-Fischer-Brauer disease) with psoriasis: A rare association showing excellent response to acitretin. J Drugs Dermatol 2005; 4: 627-634
37. Erkek E., Erdogan S., Tuncez F., et al. Type I hereditary punctate keratoderma associated with widespread lentigo simplex and successfully treated with low-dose oral acitretin. Arch Dermatol 2006; 142: 1076-1077 (Pubitemid 44268499)
38. Christophersen J., Geiger J.M., Danneskiold-Samsoe P., et al. A double-blind comparison of acitretin and etretinate in the treatment of Darier's disease. Acta Derm Venereol 1992; 72: 150-152
39. Van Dooren-Greebe R.J., Van De Kerkhof P.C., Happle R. Acitretin monotherapy in Darier's disease. Br J Dermatol 1989; 121: 375-379 (Pubitemid 19222150)
40. Chapalain V., Beylot-Barry M., Doutre M.S., et al. Treatment of pityriasis rubra pilaris: A retrospective study of 14 patients. J Dermatol Treat 1999; 10: 113-117 (Pubitemid 29348530)
41. Laurberg G., Geiger J.M., Hjorth N., et al. Treatment of lichen planus with acitretin. A double-blind, placebo-controlled study in 65 patients. J Am Acad Dermatol 1991; 24: 434-437
42. Cribier B., Frances C., Chosidow O. Treatment of lichen planus: An evidence-based medicine analysis of efficacy. Arch Dermatol 1998; 134: 1521-1530 (Pubitemid 29009252)
43. Ruzicka T., Meurer M., Bieber T. Efficiency of acitretin in the treatment of cutaneous lupus erythematosus. Arch Dermatol 1988; 124: 897-902.
44. Bousema M.T., Romppanen U., Geiger J.M., et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol 1994; 30: 225-231 (Pubitemid 24051887)
45. Thestrup-Pedersen K., Andersen K.E., Menné T., et al. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study. Acta Derm Venereol 2001; 81: 353-355 (Pubitemid 34019180)
46. Gelmetti C., Cerri D., Schiuma A.A., et al. Treatment of extensive warts with etretinate: A clinical trial in 20 children. Pediatr Dermatol 1987; 4: 254-258 (Pubitemid 18048845)
47. Iraji F., Faghihi G. Epidermodysplasia verruciformis: Association with isolated IgM deficiency and response to treatment with acitretin. Clin Exp Dermatol 2000; 25: 41-43 (Pubitemid 30117117)
48. Menter A., Korman N.J., Elmets C.A., et al. Guidelines of care for the management of psoriasis and psoriatic arthritis Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions. J Am Acad Dermatol 2011; 65: 137-174
49. Lammer E.J., Chen D.T., Hoar R.M., et al. Retinoic acid embryopathy. N Engl J Med 1985; 313: 837-841 (Pubitemid 15250197)
50. Geiger J.M., Walker M. Is there a reproductive safety risk in male patients treated with acitretin (Neotigason/Soriatane)? Dermatology 2002; 205: 105-107
51. Gollnick H.P. Oral retinoids - Efficacy and toxicity in psoriasis. Br J Dermatol 1996; 135: 6-17.
52. Orfanos C.E., Zouboulis C.C., Almond-Roesler B., Geilen C.C. Current use and future potential role of retinoids in dermatology. Drugs 1997; 53: 358-388 (Pubitemid 27117359)
53. Roenigk H.H. Jr, Callen J.P., Guzzo C.A., et al. Effects of acitretin on the liver. J Am Acad Dermatol 1999; 41: 584-588 (Pubitemid 29480409)
54. Vahlquist C., Selinus I., Vessby B. Serum-lipid changes during acitretin (etretin) treatment of psoriasis and palmoplantar pustulosis. Acta Derm Venereol 1988; 68: 300-305
55. Rood M.J., Lavrijsen S.P., Huizinga T.W. Acitretin-related ossification. J Rheumatol 2007; 34: 837-838 (Pubitemid 46641394)
56. Van Dooren-Greebe R.J., Lemmens J.A., De Boo T., et al. Prolonged treatment with oral retinoids in adults: No influence on the frequency and severity of spinal abnormalities. Br J Dermatol 1996; 134: 71-76 (Pubitemid 26030996)
57. Paige D.G., Judge M.R., Shaw D.G., et al. Bone changes and their significance in children with ichthyosis on long-term etretinate therapy. Br J Dermatol 1992; 127: 387-391
58. Starling J., Koo J. Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects. J Drugs Dermatol 2005; 4: 690-696
59. Tan S.R., Tope W.D. Effect of acitretin on wound healing in organ transplant recipients. Dermatol Surg 2004; 30: 667-673 (Pubitemid 38525899)